Bayer has reported encouraging topline findings from its global phase 3 OCEANIC-STROKE study, evaluating the investigational ...

The Academy of Medical Sciences and Wellcome have announced a new five-year agreement worth £27.3 million, reinforcing their ...

The European Commission has approved Libtayo (cemiplimab) as the first and only immunotherapy for adult patients with ...

GSK and the Fleming Initiative have announced six new research programmes to combat antimicrobial resistance (AMR), backed by ...

Cellbyte, a Munich-based AI-native platform helping pharmaceutical companies accelerate drug launches, has raised $2.75 ...

“As the first biosimilar to Simponi (golimumab) to gain approval in the European market, we are committed to expanding access ...

Biogen has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has ...

Mursla Bio has announced a new collaboration with a leading global pharmaceutical company to support biomarker-guided drug ...

Evotec has received a US$5m milestone payment from Bristol Myers Squibb following the US Food and Drug Administration’s ...

Protara Therapeutics has announced encouraging interim results from its ongoing phase 2 STARBORN-1 trial evaluating TARA-002 ...

Poolbeg Pharma has announced that the European Patent Office has granted its European Immunomodulator II patent application ...

Adocia has announced the filing of a patent for its new long-acting peptide platform, AdoXLong, aimed at improving treatment ...